Birchbrook’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.7K Buy
716
+5
+0.7% +$84 0.01% 189
2026
Q2
$11.3K Buy
711
+5
+0.7% +$77 0.01% 199
2026
Q1
$9.5K Buy
706
+106
+18% +$1.48K ﹤0.01% 201
2025
Q4
$7.47K Hold
600
– – ﹤0.01% 218
2025
Q3
$5.94K Hold
600
– – ﹤0.01% 207
2025
Q2
$5.36K Buy
+600
New +$5.07K ﹤0.01% 212

Other funds holding VTRS

Birchbrook's VTRS Position: Q3 2026 in Review

Birchbrook increased its Viatris (VTRS) stake by 0.7% in Q3 2026, buying an estimated $84 and bringing the position to 716 shares worth $12.7K. The position accounts for 0.01% of the portfolio, ranked #189.

Birchbrook first reported a position in VTRS in Q2 2025 and has held it in 6 quarters since. 351 funds tracked by Wall St. Rank hold VTRS as of Q3 2026.

  • Birchbrook held 716 shares of Viatris worth $12.7K as of Q3 2026.
  • Birchbrook bought 5 Viatris shares in Q3 2026, an estimated $84.
  • Viatris made up 0.01% of Birchbrook's portfolio in Q3 2026, its #189 holding.
  • Birchbrook first reported a position in Viatris in Q2 2025 and has held it in 6 quarters since.
  • 351 funds tracked by Wall St. Rank held Viatris as of Q3 2026.

Based on Birchbrook's 13F filing for Q3 2026, filed 14 Oct 2026.